![Klaus Maleck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Klaus Maleck
Vorstandsvorsitzender bei ITM Solucin GmbH
Profil
Klaus Maleck - Operating Partner
Klaus joined ArchiMed in 2020 as an Operating Partner.
He has over 25 years of experience in management consulting and corporate leadership in the Healthcare industry.
At ArchiMed, Klaus is particularly focused on the Biotech sector.
Klaus started his career at the Biotechnology and Genomics Center of Novartis Inc. He then joined McKinsey & Company as a Senior Consultant.
He co-founded and lead in his function as CFO BioGenerix AG, the biosimilar business of the ratiopharm group.
This was followed by Klaus assuming an executive role at Evotec AG, during which he led a major turn-around, including a Nasdaq listing and numerous corporate development activities.
Following this, he joined TETEC AG, a pioneer and market leader in cell therapy development and manufacturing, as CEO.
Klaus holds a PhD in Biochemistry from the Max-Planck Institute and an MBA.
Klaus is a German citizen and speaks fluent English.
Aktive Positionen von Klaus Maleck
Unternehmen | Position | Beginn |
---|---|---|
Tissue Engineering Technologies AG
![]() Tissue Engineering Technologies AG BiotechnologyHealth Technology Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids and analogous products. The private company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. | Corporate Officer/Principal | - |
ITM Solucin GmbH
![]() ITM Solucin GmbH Miscellaneous Commercial ServicesCommercial Services ITM Solucin GmbH provides scientific research and development services. The private company is based in Garching, Germany. The CEOs of the German company are Steffen Schuster, Klaus Maleck, Konstantin Zhernosekov. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Klaus Maleck
Unternehmen | Position | Ende |
---|---|---|
ArchiMed SAS
![]() ArchiMed SAS Investment ManagersFinance ArchiMed SAS (ArchiMed) is a private equity firm founded in 2014 by Cedric Berger, David Piccoli, and Vincent Guillaumot. The firm is headquartered in Lyon, France. | Private Equity Investor | 31.03.2023 |
European ScreeningPort GmbH | Vorsitzender | - |
EVOTEC SE | Finanzdirektor/CFO | 13.08.2010 |
Ausbildung von Klaus Maleck
University of Strasbourg | Graduate Degree |
Universität Educatis | Masters Business Admin |
Max Planck Institut für Pflanzenzüchtungsforschung | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EVOTEC SE | Health Technology |
Private Unternehmen | 4 |
---|---|
European ScreeningPort GmbH | |
Tissue Engineering Technologies AG
![]() Tissue Engineering Technologies AG BiotechnologyHealth Technology Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids and analogous products. The private company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. | Health Technology |
ITM Solucin GmbH
![]() ITM Solucin GmbH Miscellaneous Commercial ServicesCommercial Services ITM Solucin GmbH provides scientific research and development services. The private company is based in Garching, Germany. The CEOs of the German company are Steffen Schuster, Klaus Maleck, Konstantin Zhernosekov. | Commercial Services |
ArchiMed SAS
![]() ArchiMed SAS Investment ManagersFinance ArchiMed SAS (ArchiMed) is a private equity firm founded in 2014 by Cedric Berger, David Piccoli, and Vincent Guillaumot. The firm is headquartered in Lyon, France. | Finance |